The Catalan pharmaceutical company Grífols could be chosen to have naming rights to FC Barcelona’s famous stadium, Camp Nou.
As reported by RAC1 (Catalunya Radio) on Monday night, the pharmaceutical group occupies first place on the list of candidates to sponsor Barça’s stadium – and in fact the negotiations are said to be quite advanced.
Grífols was already identified as a candidate in October 2017.
At that time, Catalunya Radio assured that negotiations were taking place with the group, but the company itself categorically denied said interest. Now, it seems that it has changed its mind, and the Barça stadium could be called Camp Nou Grífols.
A month ago, Barça acknowledged that it had negotiated with Mediapro, and had rejected an offer of 165m euros (or 300m according to the company led by Jaume Roures).
According to RAC1, Barça has received offers other than those of Mediapro and Grífols, and the club’s board of directors has studied them over the past few weeks. Finally, the Catalan pharmaceutical company is likely to have been chosen and the agreement could be finalised before the end of the year.
Grífols is a pharmaceutical multinational founded in 1940, with headquarters in Barcelona and some 20,000 employees.
Its work focuses on blood derivatives, hospital machinery and bioscientific research.
Apart from this possible pact with Barcelona, the pharmaceutical company – through the investment group Scraton Enterprises – was one of those responsible for the rescue of Joventut de Badalona and has the majority of shares in the basketball club.
